14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.699 2 days ( -3.52 % )
Last Price $12.35 3.52 %
High/ Low $12.19 - $13.11 22.26%
Chg 7 Days 14.56 % $10.78 $12.35
Chg 30 Days -11.50 % $13.96 $12.35
Chg 12 mos -61.42 % $32.01 $12.35
Trend - 3 mos -38.00 % Width: 38.04 %
Trend - 12 mos -58.35 % Width: 10,501.59 %
Pred. range - 3 mos $6.00 - $8.28 -51.42 % - -32.94 %
Pred. range - 12 mos $0.0492 - $5.22 -99.60 % - -57.76 %
Short MA avg 3 mos Buy Apr 30, 2024 - 4 days
Long MA avg 3 mos Buy Mar 12, 2024 - 38 days
Short/Long MA avg 3 mos Sell Mar 07, 2024 - 41 days
Short MA avg 12 mos Buy May 01, 2024 - 3 days
Long MA avg 12 mos Sell Mar 27, 2024 - 27 days
Short/Long MA avg 12 mos Sell Apr 05, 2024 - 21 days
Pivot Short Sell Apr 25, 2024 - 7 days
Bollinger Buy Jan 25, 2024 - 70 days
MACD Buy No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About Biomea Fusion, Inc.

Biomea Fusion. Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of irreversible small molecules to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective irreversible inhibitor of menin, a transcriptional regulator in oncogenic signaling in multiple cancers. The company was incorporated in 2017 and is headquartered in R... BMEA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT